Evestia Clinical
PrivateLast Round
Debt
Jul 1, 2025
Company Overview
Evestia Clinical is a pharmaceutical and biotechnology company that provides specialized contract research organization (CRO) services for clinical trials in oncology, rare diseases, and neurodegenerative conditions.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evestia Clinical Comparables
Compare Evestia Clinical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ergomed | 93% | |
| Veristat | 87% | |
| Caidya | 86% | |
Evestia Clinical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 1, 2025 | ||||
| Buyout/LBO | Dec 9, 2024 |
Key People
Founding team and executive leadership
Evestia Clinical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kartesia | Debt |
| Kester Capital | Buyout/LBO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2025
Grew 53% QoQ, from 72 to 110 employees.
- Sep 5, 2025
Grew 24% QoQ, from 68 to 84 employees.
Evestia Clinical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Evestia Clinical's valuation, stock price, and market status.